Advertisement
Advertisement
NBP
NovaBridge Biosciences - ADR
1.60
USDSponsored
-0.04
-2.44%
Jul 31, 15:59 UTC -4
Closed
After-Market
1.64
+0.04
+2.75%
NBP Earnings Reports
Positive Surprise Ratio
NBP beat 4 of 8 last estimates.
50%
Next Report
Date of Next Report
Aug 18, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.14
Implied change from Q4 25 (Revenue/ EPS)
--
/-50.00%
Implied change from Q2 25 (Revenue/ EPS)
--
/+133.33%
NovaBridge Biosciences - ADR earnings per share and revenue
On Apr 07, 2026, NBP reported earnings of -0.28 USD per share (EPS) for Q4 25, missing the estimate of -0.05 USD, resulting in a -447.17% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.22% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.14 USD, with revenue projected to reach -- USD, implying an decrease of -50.00% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Agios Pharmaceuticals, Inc.
Report Date
Jul 30, 2026 For Q2 26
Estimate
-$1.70
Actual
-$1.69
Surprise
+0.66%
Castle Biosciences, Inc. Common Stock
Report Date
Jul 30, 2026 For Q2 26
Estimate
-$0.41
Actual
-$0.07
Surprise
+83.12%
Myriad Genetics Inc
Report Date
Jul 30, 2026 For Q2 26
Estimate
-$0.05
Actual
-$0.25
Surprise
-323.73%
Crescent Biopharma, Inc. Common Stock
Report Date
Jul 30, 2026 For Q2 26
Estimate
-$0.81
Actual
-$0.74
Surprise
+8.74%
Bristol-Myers Squibb Co.
Report Date
Jul 30, 2026 For Q2 26
Estimate
$1.60
Actual
$2.04
Surprise
+27.20%
Regeneron Pharmaceuticals Inc
Report Date
Jul 30, 2026 For Q2 26
Estimate
$10.46
Actual
$14.29
Surprise
+36.51%
Moderna, Inc. Common Stock
Report Date
Jul 31, 2026 For Q2 26
Estimate
-$2.12
Actual
-$1.97
Surprise
+7.28%
Illumina Inc
Report Date
Jul 30, 2026 For Q2 26
Estimate
$1.38
Actual
$1.31
Surprise
-5.30%
Guardant Health, Inc. Common Stock
Report Date
Jul 30, 2026 For Q2 26
Estimate
-$0.41
Actual
-$0.42
Surprise
-0.02%
PTC Therapeutics, Inc.
Report Date
Jul 30, 2026 For Q2 26
Estimate
$0.42
Actual
$0.92
Surprise
+116.37%
FAQ
What were NovaBridge Biosciences - ADR's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, NovaBridge Biosciences - ADR reported EPS of -$0.28, missing estimates by -447.17%, and revenue of $0.00, 0% as expectations.
How did the market react to NovaBridge Biosciences - ADR's Q4 2025 earnings?
The stock price moved down -1.22%, changed from $2.46 before the earnings release to $2.43 the day after.
When is NovaBridge Biosciences - ADR expected to report next?
The next earning report is scheduled for Aug 18, 2026.
What are the forecasts for NovaBridge Biosciences - ADR's next earnings report?
Based on --
analysts, NovaBridge Biosciences - ADR is expected to report EPS of -$0.14 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement